Skip to main content
. 2020 Oct 12;15:7825–7840. doi: 10.2147/IJN.S268208

Figure 5.

Figure 5

Bar graph representing the antifungal activity of voriconazole based niosomal ocuserts with different concentrations: 0.5% w/w (i), 0.75% w/w (ii), 1% w/w (iii), matched with natamycin 5% eye drops (iv) against Candida albicans.